Literature DB >> 21360818

High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors.

Edmund J Keliher1, Thomas Reiner, Anna Turetsky, Scott A Hilderbrand, Ralph Weissleder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21360818      PMCID： PMC3136544          DOI： 10.1002/cmdc.201000426

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  34 in total

Review 1.  Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.

Authors:  Dana V Ferraris
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Bioorthogonal turn-on probes for imaging small molecules inside living cells.

Authors:  Neal K Devaraj; Scott Hilderbrand; Rabi Upadhyay; Ralph Mazitschek; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-19       Impact factor: 15.336

3.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Authors:  N Avril; C A Rosé; M Schelling; J Dose; W Kuhn; S Bense; W Weber; S Ziegler; H Graeff; M Schwaiger
Journal:  J Clin Oncol       Date:  2000-10-15       Impact factor: 44.544

4.  Copper-free click chemistry in living animals.

Authors:  Pamela V Chang; Jennifer A Prescher; Ellen M Sletten; Jeremy M Baskin; Isaac A Miller; Nicholas J Agard; Anderson Lo; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-14       Impact factor: 11.205

5.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Authors:  Matthias Nahrendorf; Edmund Keliher; Peter Panizzi; Hanwen Zhang; Sheena Hembrador; Jose-Luiz Figueiredo; Elena Aikawa; Kimberly Kelly; Peter Libby; Ralph Weissleder
Journal:  JACC Cardiovasc Imaging       Date:  2009-10

6.  Tetrazine-based cycloadditions: application to pretargeted live cell imaging.

Authors:  Neal K Devaraj; Ralph Weissleder; Scott A Hilderbrand
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

7.  Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition.

Authors:  Neal K Devaraj; Rabi Upadhyay; Jered B Haun; Scott A Hilderbrand; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  A click chemistry approach to tetrazoles by Huisgen 1,3-dipolar cycloaddition: synthesis of 5-sulfonyl tetrazoles from azides and sulfonyl cyanides.

Authors:  Zachary P Demko; K Barry Sharpless
Journal:  Angew Chem Int Ed Engl       Date:  2002-06-17       Impact factor: 15.336

9.  A photochemical synthesis of functionalized trans-cyclooctenes driven by metal complexation.

Authors:  Maksim Royzen; Glenn P A Yap; Joseph M Fox
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

10.  A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems.

Authors:  Nicholas J Agard; Jennifer A Prescher; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2004-11-24       Impact factor: 15.419
View more
  47 in total

1.  Synthesis and evaluation of a series of 1,2,4,5-tetrazines for bioorthogonal conjugation.

Authors:  Mark R Karver; Ralph Weissleder; Scott A Hilderbrand
Journal:  Bioconjug Chem       Date:  2011-10-24       Impact factor: 4.774

Review 2.  Expanding room for tetrazine ligations in the in vivo chemistry toolbox.

Authors:  Jolita Sečkutė; Neal K Devaraj
Journal:  Curr Opin Chem Biol       Date:  2013-09-07       Impact factor: 8.822

Review 3.  18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography.

Authors:  Hema S Krishnan; Longle Ma; Neil Vasdev; Steven H Liang
Journal:  Chemistry       Date:  2017-09-01       Impact factor: 5.236

Review 4.  New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions.

Authors:  Graham Smith; Laurence Carroll; Eric O Aboagye
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

5.  Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer.

Authors:  Dong Zhou; Jinbin Xu; Cedric Mpoy; Wenhua Chu; Sung Hoon Kim; Huifangjie Li; Buck E Rogers; John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2018-08-24       Impact factor: 2.408

6.  Synthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography.

Authors:  Dong Zhou; Wenhua Chu; Jinbin Xu; Lynne A Jones; Xin Peng; Shihong Li; Delphine L Chen; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2014-01-24       Impact factor: 3.641

Review 7.  Click chemistry in complex mixtures: bioorthogonal bioconjugation.

Authors:  Craig S McKay; M G Finn
Journal:  Chem Biol       Date:  2014-09-18

8.  Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine.

Authors:  Jongho Jeon; Bin Shen; Liqin Xiong; Zheng Miao; Kyung Hyun Lee; Jianghong Rao; Frederick T Chin
Journal:  Bioconjug Chem       Date:  2012-08-10       Impact factor: 4.774

9.  Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.

Authors:  Brandon Carney; Giuseppe Carlucci; Beatriz Salinas; Valentina Di Gialleonardo; Susanne Kossatz; Axel Vansteene; Valerie A Longo; Alexander Bolaender; Gabriela Chiosis; Kayvan R Keshari; Wolfgang A Weber; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

10.  Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.

Authors:  Maulik D Majmudar; Edmund J Keliher; Timo Heidt; Florian Leuschner; Jessica Truelove; Brena F Sena; Rostic Gorbatov; Yoshiko Iwamoto; Partha Dutta; Gregory Wojtkiewicz; Gabriel Courties; Matt Sebas; Anna Borodovsky; Kevin Fitzgerald; Marc W Nolte; Gerhard Dickneite; John W Chen; Daniel G Anderson; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circulation       Date:  2013-04-24       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.